SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-406743"
 

Search: onr:"swepub:oai:DiVA.org:uu-406743" > An in vitro dissolu...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Alvebratt, CarolineUppsala universitet,Institutionen för farmaci (author)

An in vitro dissolution–digestion–permeation assay for the study of advanced drug delivery systems

  • Article/chapterEnglish2020

Publisher, publication year, extent ...

  • Elsevier BV,2020
  • electronicrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-406743
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-406743URI
  • https://doi.org/10.1016/j.ejpb.2020.01.010DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Advanced drug delivery systems (ADDS) are widely explored to overcome poor aqueous solubility of orally administered drugs. However, the prediction of their in vivo performance is challenging, as in vitro models typically do not capture the interplay between processes occurring in the gut. In additions, different models are used to evaluate the different systems. We therefore present a method that allows monitoring of luminal processing (dissolution, digestion) and its interplay with permeation to better inform on the absorption of felodipine formulated as ADDS. Experiments were performed in a µFLUX-apparatus, consisting of two chambers, representing the intestinal and serosal compartment, separated by Caco-2 monolayers. During dissolution–digestion–permeation experiments, ADDS were added to the donor compartment containing simulated intestinal fluid and immobilized lipase. Dissolution and permeation in both compartments were monitored using in situ UV-probes or, when turbidity interfered the measurements, with HPLC analysis.The method showed that all ADDS increased donor and receiver concentrations compared to the condition using crystalline felodipine. A poor correlation between the compartments indicated the need for an serosal compartment to evaluate drug absorption from ADDS. The method enables medium-throughput assessment of: (i) dynamic processes occurring in the small intestine, and (ii) drug concentrations in real-time.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Keemink, JannekeUppsala universitet,Institutionen för farmaci(Swepub:uu)janke374 (author)
  • Edueng, KhadijahUppsala universitet,Institutionen för farmaci(Swepub:uu)khaed265 (author)
  • Cheung, OceanUppsala universitet,Nanoteknologi och funktionella material(Swepub:uu)ocech274 (author)
  • Strömme, Maria,1970-Uppsala universitet,Nanoteknologi och funktionella material(Swepub:uu)mst26208 (author)
  • Bergström, Christel,1973-Uppsala universitet,Institutionen för farmaci(Swepub:uu)cjo29958 (author)
  • Uppsala universitetInstitutionen för farmaci (creator_code:org_t)

Related titles

  • In:European journal of pharmaceutics and biopharmaceutics: Elsevier BV149, s. 21-290939-64111873-3441

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view